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Introduction
The receptor for advanced glycation end products
(RAGE) is a multi-ligand receptor expressed on various
cells which interacts with a diverse class of ligands, e.g.
‘danger signals’ such as neutrophil-derived S100A12.
RAGE has been implicated in the pathogenicity of various
inflammatory diseases. However, the exact role of RAGE
has not been sufficiently defined. Our recent data on
S100A12-induced activation of monocytes points to a
modulatory rather than pro-inflammatory function of
human RAGE.
Objectives
To assess the role of RAGE in a more systematic way,
we generated RAGE-/- mice and analyzed immune cell
functions in vitro, followed by murine models of staphy-
lococcus aureus infection (dermal immunity), chemically
induced colitis (mucosal immunity), lethal inflammatory
liver injury (septic shock) and collagen induced arthritis
(autoimmunity) comparing RAGE-/- and C57BL/6 wild-
type (wt) mice.
Methods
Reactive oxygen species (ROS) production, phagocytosis
and cytokine production of bone marrow derived mono-
cytes were measured using flow cytometry. Staphylococ-
cus aureus (S. aureus) infection was induced by footpad
injection. Acute and chronic colitis were induced chemi-
cally by dextran sodium sulfate (DSS) solution. For the
inflammatory liver injury model, mice were challenged
with D-galactosamine (D-Gal) along with lipopolysac-
charide (LPS). Arthritis was induced by injection of het-
erologous type II collagen (CII).
Results
We observed no differences of cellular immune function
(ROS and cytokine production, phagocytosis) in
RAGE-/- compared to wt monocytes. Male, but not
female RAGE-/- mice showed more footpad swelling
and bacterial dissemination in the S. aureus infection
model. In the DSS colitis model we observed no signifi-
cant differences between the two strains, whereas
RAGE-/- mice were significantly protected from lethal
D-Gal/LPS induced liver injury. RAGE-/- and wt mice
develop arthritis at similar clinical scores and incidence
with no detectable differences in type II collagen autoanti-
body levels. However, in female animals there is a strong
tendency towards aggravated disease, less remission and
higher disease penetrance.
Conclusion
Overall, the contribution of RAGE seems to largely
depend on the disease model and cell type studied. While
no overall differences with respect to immune cell activ-
ities were observed, a striking gender specific effect of
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